Try it
Orthopaedics · Metabolic bone disease: aluminium bone disease
Sample itemA dialysis patient taking aluminium hydroxide as a phosphate binder for many years has bone pain and fractures. PTH is low and a bone biopsy shows osteomalacia with aluminium at the mineralisation front. What is the diagnosis?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Aluminium-related low-turnover bone disease
Aluminium deposited at the mineralisation front blocks mineralisation and suppresses PTH, causing low-turnover osteomalacia and adynamic bone. Avoidance of aluminium-based binders and chelation prevent and treat it.
Option by option
A. Brown tumour of hyperparathyroidism
A brown tumour arises from severe hyperparathyroidism with raised PTH.
B. Osteitis fibrosa cystica
Osteitis fibrosa cystica comes from high PTH with a high-turnover pattern.
C. Dialysis-related amyloid arthropathy
Amyloid arthropathy results from beta-2 microglobulin deposition, not from aluminium.
D. Aluminium-related low-turnover bone disease (correct)
Correct. Aluminium at the mineralisation front with low PTH identifies aluminium bone disease.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Orthopaedics questions
- Upper limb fracturesWhich complication is characteristic of a fracture through the waist of the scaphoid?
- Fractures in childrenA child with a displaced supracondylar fracture of the humerus develops a painful, pale…
- Bone tumoursA teenager has knee pain and a radiograph around the distal femur showing a sunburst per…
- HipA positive Trendelenburg sign is due to weakness of the gluteus medius and minimus. Whic…